Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services today announced MyHealthEData, a federal initiative to expand patient access to their medical data electronically.
Hospital emergency department visits for suspected opioid overdoses increased 30% from July 2016 through September 2017, to 142,557.
Hospira is voluntarily recalling three lots of the injectable opioid medication Hydromorphone HCl because the glass vials may be broken or cracked.
The AHA and seven other national organizations today urged Congress to “oppose any unwarranted legislative attempts that would undermine the successful efforts by the medical community and professional training organizations to create a unified accreditation system for graduate medical education.”
According to a randomized trial reported today in the Journal of the American Medical Association, opioids are no better than non-opioid medications at treating chronic back pain or hip or knee osteoarthritis pain.
The Centers for Medicare & Medicaid Services yesterday deferred a proposal by Arkansas to reduce income eligibility for adults in its Medicaid program from 138% to 100% of the federal poverty level.
Hospitals continue to have serious concerns that Anthem's coverage policies for outpatient imaging and emergency care services are detrimental to patients, diminishing access to care and driving care location based on the lowest cost provider, AHA and other hospitals groups told the insurer today.
"In times of disasters, outbreaks and tragedies, communities lean on their hospitals: That fact will never change."
A recent opinion piece in The Hill “gives readers a one-sided, misleading and misinformed view on the issue of site-neutral payment proposals and consolidation in the health field.”
AHA voiced strong support for the Centers for Medicare & Medicaid Services’ proposal to expand the types of supplemental benefits that MA plans can offer to better manage beneficiary health.